Clinical Manifestations of Ocular Toxoplasmosis

By Delair Emmanuelle   Latkany Paul   Noble A. Gwendolyn   Rabiah Peter   McLeod Rima   Bréézin Antoine  

Ocular Immunology and Inflammation, Vol. 19, Iss. 2, 2011-04 ,pp. : 91-102

Informa Healthcare

Access to resources Recommend Favorite

Therapy for Ocular Toxoplasmosis

By de-la-Torre Alejandra   Stanford Miles   Curi Andre   Jaffe Glenn J.   Gomez-Marin Jorge E.  

Ocular Immunology and Inflammation, Vol. 19, Iss. 5, 2011-10 ,pp. : 314-320

Informa Healthcare

Access to resources Recommend Favorite

Epidemiology of Ocular Toxoplasmosis

By Petersen Eskild   Kijlstra Aize   Stanford Miles  

Ocular Immunology and Inflammation, Vol. 20, Iss. 2, 2012-04 ,pp. : 68-75

Informa Healthcare

Access to resources Recommend Favorite

Therapy for Ocular Toxoplasmosis – The Future

By Garweg Justus G.   Stanford Miles R.  

Ocular Immunology and Inflammation, Vol. 21, Iss. 4, 2013-08 ,pp. : 300-305

Informa Healthcare

Access to resources Recommend Favorite

Toxoplasmosis, an overview with emphasis on ocular involvement

By Klaren Vincent N.A.   Kijlstra Aize  

Ocular Immunology and Inflammation, Vol. 10, Iss. 1, 2002-03 ,pp. : 1-26

Informa Healthcare

Access to resources Recommend Favorite